Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-21

FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal's original application for a generic fixed-dose combination of ezetimibe and simvastatin (EZETIMIBE AND SIMVASTATIN). This approval makes th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

ORIG AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)